Skip to content
Home/Companies/HealthTech/Predilepsy
PR

Predilepsy

HealthTech·France·Active·5yr hold

Predilepsy is a digital health company, headquartered in France.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Predilepsy?

Predilepsy is currently owned by Elaia Partners through Elaia Endowment Fund (2020 vintage), since 2021.

Hand-verified · updated 2026-04-21

Elaia Partners
Investor
Elaia Partners
Elaia Endowment Fund · 2020 · VC

Key facts

HQFrance
SectorDigital Health

More from Elaia Endowment Fund

Other portfolio companies in the same fund.

QBio JRC
Active
BiotechFrance· 2022
Sensation Quantique
Active
HealthTechFrance· 2022
Pyronear
Active
SoftwareFrance· 2021
Institut Analgesia
Active
HealthTechFrance· 2020

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings